ClinConnect ClinConnect Logo
Search / Trial NCT06291649

Multicentre Prospective Observational Study of Acute Intoxications in Paediatric Age

Launched by MEYER CHILDREN'S HOSPITAL IRCCS · Feb 26, 2024

Trial Information

Current as of July 12, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying acute intoxications in children, which occur when kids accidentally come into contact with harmful substances. The goal is to understand how often these incidents happen and what social and healthcare factors may contribute to them. By gathering this information, researchers hope to improve the way we diagnose and treat these situations in the future. The study is being conducted at several hospitals and poison control centers across the country.

To participate in the study, children aged between 1 month and 16 years who experience an acute intoxication can be included. This means if a child has been exposed to a toxic substance or has ingested something harmful, they may be eligible to take part. Parents or guardians will be asked to give their permission for their child to join the study. Participants will help researchers understand more about these incidents, which can ultimately lead to better care and prevention strategies for children at risk of poisoning.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subjects between the ages of 1 month and 16 years who report to the PSPs or contact by telephone the CAVs participating in the study with acute intoxication (defined as contact with a substance that is toxic per se or in such quantities as to cause a harmful effect on the body or administered by a route not intended for that substance)
  • Exclusion Criteria:
  • not acquired informed consent

About Meyer Children's Hospital Irccs

Meyer Children's Hospital IRCCS is a leading pediatric research institution based in Italy, dedicated to advancing child healthcare through innovative clinical trials and research initiatives. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it combines clinical excellence with rigorous scientific inquiry, focusing on various pediatric conditions. The hospital collaborates with multidisciplinary teams to enhance treatment protocols, improve patient outcomes, and contribute to the global body of knowledge in pediatric medicine. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the highest level of integrity and care.

Locations

Pavia, , Italy

Rimini, , Italy

Roma, , Italy

Bologna, , Italy

Empoli, , Italy

Vicenza, , Italy

Nuoro, , Italy

Cagliari, , Italy

Prato, , Italy

Torino, , Italy

Pistoia, , Italy

Grosseto, , Italy

Florence, , Italy

Florence, Firenze, Italy

Bagno A Ripoli, Firenze, Italy

Borgo San Lorenzo, Firenze, Italy

Forlì, Forlì Cesena, Italy

Legnago, Verona, Italy

Bolzano, , Italy

Messina, , Italy

Padova, , Italy

Parma, , Italy

Pescara, , Italy

Pisa, , Italy

Pordenone, , Italy

Roma, , Italy

Trento, , Italy

Treviso, , Italy

Trieste, , Italy

Udine, , Italy

Verona, , Italy

Verona, , Italy

Forlì, , Italy

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported